Publications
Detailed Information
Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein : Involvement of NF-kappa B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Su-Hyeong | - |
dc.contributor.author | Oh, Jung-Min | - |
dc.contributor.author | No, Jae-Hong | - |
dc.contributor.author | Bang, Yung-Jue | - |
dc.contributor.author | Juhnn, Yong-Sung | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.date.accessioned | 2012-05-31T08:10:28Z | - |
dc.date.available | 2012-05-31T08:10:28Z | - |
dc.date.created | 2018-01-19 | - |
dc.date.issued | 2009-05 | - |
dc.identifier.citation | Carcinogenesis, Vol.30 No.5, pp.753-757 | - |
dc.identifier.issn | 0143-3334 | - |
dc.identifier.other | 24723 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76705 | - |
dc.description.abstract | The human papillomavirus (HPV) E6 and E7 oncoproteins play important roles in cervical carcinogenesis through multiple mechanisms, including upregulation of cyclooxygenase-2 (COX-2), which has been shown to be involved in both carcinogenesis and cancer progression. To explore the role of E5 in cervical carcinogenesis, we herein investigated the effect of HPV 16 E5 on COX-2 expression. Our results revealed that E5 induced COX-2 expression through the epidermal growth factor receptor-signaling pathway, with nuclear factor-kappaB (NF-kappa B) and activator protein-1 (AP-1) acting as critical factors in E5-induced COX-2 expression. NF-kappa B inhibition blocked COX-2 expression more potently than inhibition of AP-1. Our findings collectively suggest that the HPV 16 E5 oncoprotein mediates cervical carcinogenesis at least in part via upregulation of COX-2 expression through NF-kappa B and AP-1, with NF-kappa B playing a larger role. | - |
dc.language | 영어 | - |
dc.language.iso | en | ko_KR |
dc.publisher | Oxford University Press | - |
dc.title | Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein | - |
dc.title.alternative | Involvement of NF-kappa B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 방영주 | - |
dc.identifier.doi | 10.1093/carcin/bgp066 | - |
dc.citation.journaltitle | Carcinogenesis | - |
dc.description.citedreference | Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273 | - |
dc.description.citedreference | Ishikawa H, 2006, INT J RADIAT ONCOL, V66, P1347, DOI 10.1016/j.ijrobp.2006.07.007 | - |
dc.description.citedreference | Kang SB, 2006, CANCER LETT, V237, P305, DOI 10.1016/j.canlet.2005.06.027 | - |
dc.description.citedreference | Kim SH, 2006, CELL MOL LIFE SCI, V63, P930, DOI 10.1007/s00018-005-5561-x | - |
dc.description.citedreference | Kim SH, 2004, J CANCER RES CLIN, V130, P551, DOI 10.1007/s00432-004-0567-6 | - |
dc.description.citedreference | Pruthi RS, 2004, BJU INT, V93, P275, DOI 10.1111/j.1464-410X.2004.04601.x | - |
dc.description.citedreference | Hallak A, 2003, DIGEST DIS SCI, V48, P1998 | - |
dc.description.citedreference | Kim MH, 2003, GYNECOL ONCOL, V90, P83, DOI 10.1016/S0090-8258(03)00224-5 | - |
dc.description.citedreference | Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96 | - |
dc.description.citedreference | Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200 | - |
dc.description.citedreference | ZUR HH, 2002, NAT REV CANCER, V2, P342 | - |
dc.description.citedreference | Zhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002 | - |
dc.description.citedreference | Anderson WF, 2002, CURR PHARM DESIGN, V8, P1035 | - |
dc.description.citedreference | Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X | - |
dc.description.citedreference | Guo YS, 2001, J BIOL CHEM, V276, P22941 | - |
dc.description.citedreference | Gaffney DK, 2001, INT J RADIAT ONCOL, V49, P1213 | - |
dc.description.citedreference | Kulkarni S, 2001, CLIN CANCER RES, V7, P429 | - |
dc.description.citedreference | Crusius K, 1998, EXP CELL RES, V241, P76 | - |
dc.description.citedreference | Ristimaki A, 1997, CANCER RES, V57, P1276 | - |
dc.description.citedreference | Luque I, 1997, SEMIN CANCER BIOL, V8, P103 | - |
dc.description.citedreference | ZUR HH, 1994, ANNU REV MICROBIOL, V48, P427 | - |
dc.description.citedreference | STRAIGHT SW, 1993, J VIROL, V67, P4521 | - |
dc.description.citedreference | WERNESS BA, 1990, SCIENCE, V248, P76 | - |
dc.description.citedreference | HAWLEYNELSON P, 1989, EMBO J, V8, P3905 | - |
dc.description.citedreference | KAUR P, 1989, J GEN VIROL, V70, P1261 | - |
dc.description.citedreference | DYSON N, 1989, SCIENCE, V243, P934 | - |
dc.description.tc | 16 | - |
dc.identifier.wosid | 000265740000005 | - |
dc.identifier.scopusid | 2-s2.0-65549096389 | - |
dc.citation.endpage | 757 | - |
dc.citation.number | 5 | - |
dc.citation.startpage | 753 | - |
dc.citation.volume | 30 | - |
dc.identifier.sci | 000265740000005 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Bang, Yung-Jue | - |
dc.contributor.affiliatedAuthor | Juhnn, Yong-Sung | - |
dc.contributor.affiliatedAuthor | Song, Yong-Sang | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | HUMAN FORESKIN KERATINOCYTES | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | CERVICAL-CANCER | - |
dc.subject.keywordPlus | CYCLOOXYGENASE-2 EXPRESSION | - |
dc.subject.keywordPlus | INDUCED APOPTOSIS | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | TYPE-16 | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | CARCINOMA | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.